UNSPSC 51182500: Combination antithyroid agents and supplements

This classification denotes combination drugs used to treat hyperthyroidism by reducing the excessive production of thyroid hormones, hence the term ANTITHYROID AGENTS. Typical combination antithyroid agent and supplement constituents are iodine and levothyroxine.

UNSPSC 51182500 Combination antithyroid agents and supplements is a Class code under which state and local governments purchase pharmaceutical products used to treat thyroid conditions, typically through health department procurement, institutional healthcare systems, and medicaid programs. The code encompasses combination formulations that address hypothyroidism, hyperthyroidism, and related thyroid disorders — drugs such as levothyroxine combined with liothyronine, or antithyroid medications paired with adjunctive supplements that support thyroid function and treatment outcomes. State and local buying entities include state health departments, county health services, municipal hospitals and clinics, school district health services, and state medicaid agencies that source these agents for clinical use, patient care programs, and public health initiatives.

The source provided contains no recent state or local contract opportunities posted under this code, and therefore does not support characterization of geographic spread, issuing-body concentration, or representative recent solicitations at this time.